Anthony Peter Ottridge

Title: Innovations of Anthony Peter Ottridge in Phthalazinone Derivatives

Introduction

Anthony Peter Ottridge is an accomplished inventor based in Cambridge, GB, known for his significant contributions to the field of pharmaceuticals. With a total of two patents to his name, he has focused his efforts on developing innovative drug compounds that could aid in therapeutic applications.

Latest Patents

Ottridge's latest inventions include two notable patents related to phthalazinone derivatives. The first patent features the compound 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one as crystalline Form A. His second patent closely mirrors the first, similarly describing the same compound in crystalline Form A. These inventions demonstrate his expertise in medicinal chemistry and the potential for advancements in pharmaceutical formulations.

Career Highlights

Currently, Anthony Peter Ottridge holds a position at Kudos Pharmaceuticals Limited, where he continues to explore innovative solutions in drug development. His work not only emphasizes the importance of structural advancements in pharmaceutical chemistry but also highlights the potential for new therapeutic applications.

Collaborations

Throughout his career, Ottridge has collaborated with esteemed colleagues such as Keith Allan Menear and Derek John Londesbrough. These collaborations have fostered a conducive environment for creativity and innovation within Kudos Pharmaceuticals Limited, allowing them to push the boundaries of medicinal research further.

Conclusion

In summary, Anthony Peter Ottridge stands out as an inventive mind in the pharmaceutical industry with a keen focus on phthalazinone derivatives. His patents contribute valuable insights into drug development, reinforcing the critical role of inventors like him in advancing healthcare solutions.